Gossamer Bio, Inc. Common Stock

GOSSNASDAQ • USD
10.59 USD
↘ 0.39 (3.56%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

Gossamer Bio, Inc. Common Stock (GOSS) is currently trading at $10.59. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (101.9%) and a bearish Death Cross on the long-term moving averages. On the valuation side, GOSS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$10.85
High?$11.37
Low?$10.27
Prev. Close?$10.98
Volume?121.2K
Avg. Volume?200.6K
VWAP?$10.83
Rel. Volume?0.60x
Bid / Ask
Bid?$10.32 × 300
Ask?$12.12 × 100
Spread?$1.80
Midpoint?$11.22
Valuation & Ratios
Market Cap?67.2M
Shares Out?6.1M
Float?5.8M
Float %?94.3%
P/E Ratio?N/A
P/B Ratio?-0.55
EPS?-$20.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Employees
162
Market Cap
67.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-02-08
Address
3115 MERRYFIELD ROW
SAN DIEGO, CA 92121
Phone: (858) 684-1300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
93
Short Sent.?
50
Piotroski F-Score?2/9Weak
Altman Z-Score?-37.94Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.22%Squeeze Risk
Short Interest?1.3M
Days to Cover?7.5
Free Float5.8M
Avg Daily Volume178.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.60Weak
Quick Ratio?0.60Weak
Cash Ratio?0.51Adequate
Debt/Equity?-0.30Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.55CHEAP▾
P/S?
Peers
100
S&P
89
0.86CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.68CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
101.9%STRONG▾
ROA?
S&P
3
-194.4%WEAK▾
Cash Flow & Enterprise
FCF?$-156038000
Enterprise Value?$53.1M
Fundamentals ratios updated end of day